Companies

The key players operating in the global sciatica market are focusing on vigorous product pipeline for the treatment of sciatica which are estimated to launch over the forecast period, is expected to drive the growth of the global sciatica market. For instance, on September 4, 2019, SpineThera Australia Pty Ltd, a wholly owned subsidiary of SpineThera, Inc., initiated a phase I/II clinical trial study to assess the safety and efficacy of two doses of SX600 administered by lumbosacral transforaminal epidural injection in patients with radicular pain secondary to lumbar intervertebral disc herniation. The study is estimated to complete by September 2022.

Sciatica Market Report Coverage

Report Coverage	Details
Base Year:	2020	Market Size in 2021:	US$ 6,302.9 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2021 to 2028
Forecast Period 2021 to 2028 CAGR:	4.8%	2028 Value Projection:	US$ 8,776.2 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Disease Type: Acute Sciatica, Chronic Sciatica, Others By Drug Class: Nonsteroidal Anti-Inflammatory Drugs, Oral Steroids, Anticonvulsant Agents, Tricyclic Antidepressants, Opioid Analgesics, Others By Route of Administration: Oral, Injectable By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:	Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC., Mylan N.V., Horizon Therapeutics Plc., Sun Pharmaceutical Industries Ltd., Alkem Labs, SCILEX Pharmaceuticals, Inc., Seikagaku Corporation, Kolon Life Science, Inc., Teijin Limited, and SpineThera, Inc
Growth Drivers:	Increasing incidence and prevalence of sciatica Robust product pipeline
Restraints & Challenges:	Potential side effects of drugs used in the treatment of sciatica